GlassScriptPhysician profile
Bryanna Vesely
NPI 1972122885
$15,683.01
in general payments reported to CMS, 2019-2025
12 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.99 · 2023: $673 · 2024: $14K · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $2,833 · Food and Beverage: $2,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $2,832.99 |
| Food and Beverage | $2,765.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,251.51 | 2022-2024 | |
| Fortis Surgical, LLC | $1,585.28 | 2024-2025 | |
| Stryker Corporation | $471.96 | 2024-2025 | Gamma, Augment Injectable, Dart-Fire |
| Integra Lifesciences Corporation | $448.22 | 2023-2025 | Tenoglide, Integra, Integra Dermal Regeneration Template |
| Axogen | $310.73 | 2023 | Avance Nerve Graft |
| Lifenet Health | $156.97 | 2025 | Theragenesis Wound Matrix |
| Organogenesis INC. | $138.75 | 2023-2024 | Puraply |
| Goode Surgical INC | $108.17 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $88.90 | 2023 | Nuzyra |
| Electronic Waveform Lab, INC. | $50.30 | 2024 | |
| Treace Medical Concepts, INC. | $43.91 | 2024 | |
| Ethicon US, LLC | $28.31 | 2024 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryanna Vesely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.